Assembly Biosciences (ASMB) Other Accumulated Expenses (2018 - 2026)

Assembly Biosciences' Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• On a quarterly basis, Other Accumulated Expenses fell 26.97% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a 26.97% decrease from a year earlier, with the FY2025 full-year figure at $7.7 million, up 12.93% from the prior year.
• Other Accumulated Expenses retreated to $1.5 million in Q1 2026 per ASMB's latest filing, from $7.7 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $7.7 million in Q4 2025 and bottomed at $1.5 million in Q1 2026.
• The 5-year median for Other Accumulated Expenses is $3.2 million (2023), against an average of $3.7 million.
• Across the five-year window, Other Accumulated Expenses sank 59.19% in 2024 and soared 92.81% in 2025, its largest moves.
• Year by year, Other Accumulated Expenses stood at $3.1 million in 2022, then surged by 83.98% to $5.7 million in 2023, then grew by 19.46% to $6.9 million in 2024, then rose by 12.93% to $7.7 million in 2025, then tumbled by 80.15% to $1.5 million in 2026.
• Per Business Quant, the three latest ASMB Other Accumulated Expenses figures stand at $1.5 million (Q1 2026), $7.7 million (Q4 2025), and $3.1 million (Q3 2025).